BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33656378)

  • 1. Fatty Pancreas: An Underappreciated Intersection of the Metabolic Profile and Pancreatic Adenocarcinoma.
    Swislocki A
    Metab Syndr Relat Disord; 2021 Aug; 19(6):317-324. PubMed ID: 33656378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty pancreas disease - practices for clinicians.
    Pinte L; Balaban DV; Băicuş C; Jinga M
    Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Implications of Fatty Pancreas: A Concise Review.
    Khoury T; Asombang AW; Berzin TM; Cohen J; Pleskow DK; Mizrahi M
    Dig Dis Sci; 2017 Oct; 62(10):2658-2667. PubMed ID: 28791556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
    Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic steatosis and metabolic pancreatic disease: a new entity?
    Caldart F; de Pretis N; Luchini C; Ciccocioppo R; Frulloni L
    Intern Emerg Med; 2023 Nov; 18(8):2199-2208. PubMed ID: 37462859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
    Jermendy G
    Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.
    Chang ML
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty pancreas disease.
    Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
    Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
    Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
    Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
    Biadgo B; Abebe M
    Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
    Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
    Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pancreas.
    Laugier R; Sarles H
    Clin Gastroenterol; 1985 Oct; 14(4):749-56. PubMed ID: 2417759
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective evaluation of fatty pancreas by using EUS.
    Sepe PS; Ohri A; Sanaka S; Berzin TM; Sekhon S; Bennett G; Mehta G; Chuttani R; Kane R; Pleskow D; Sawhney MS
    Gastrointest Endosc; 2011 May; 73(5):987-93. PubMed ID: 21521567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.
    Lesmana CR; Pakasi LS; Inggriani S; Aidawati ML; Lesmana LA
    BMC Gastroenterol; 2015 Dec; 15():174. PubMed ID: 26652175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlarged pancreas: not always a cancer.
    Calculli L; Festi D; Pezzilli R
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):107-8. PubMed ID: 25655299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between nonalcoholic fatty pancreas disease and diabetes.
    Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
    PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
    Catanzaro R; Cuffari B; Italia A; Marotta F
    World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Steatosis: An Emerging Clinical Entity.
    Ramkissoon R; Gardner TB
    Am J Gastroenterol; 2019 Nov; 114(11):1726-1734. PubMed ID: 31185002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of pancreatic steatosis.
    Smits MM; van Geenen EJ
    Nat Rev Gastroenterol Hepatol; 2011 Mar; 8(3):169-77. PubMed ID: 21304475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.